Hyaluronan mimetics may extend late-life survival by blocking cell fusion
In old mice, a treatment that mimics a matrix of long hyaluronan chains may extend remaining life by blocking fusion between abnormal epithelial cells and macrophages. Full protection after introducing preformed, genetically confirmed hybrids would refute fusion prevention as the leading mechanism.
Stage of verification
- Hypothesis published2026-10-05
- Not enough research data
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Rhythm or programme
Cell fusion
The merging of separate cells into a multinucleated cell with shared cytoplasm
Where this hypothesis actsPathological epithelial cells and macrophages in aged tissue undergoing repeated injury
Hypotheses on this target 2
Inhibition1
Activation
Function preservation
Feedback restoration
Rhythm restoration
Direct measurement
What is proposed
Suppress fusion between pathological epithelial cells and macrophages
HowUse long hyaluronan chains to occupy CD44 and prevent initiation of fusion, while preserving phagocytosis and immune cytotoxicity
Possible result
Possible reduction in invasive tumours and preservation of a lifespan benefit despite persistence of mutant cells
From the recordДлинные цепи гиалуронана занимают рецептор CD44 и препятствуют запуску программы слияния при повторном повреждении.
Enzyme
Hyaluronan synthase 2
An enzyme that synthesizes hyaluronan
Where this hypothesis actsThe naked mole-rat enzyme in aged tissue undergoing repeated injury
Hypotheses on this target 1- Inhibition
- Activation1
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression- Function preservation
What is proposed
Activation
Increase hyaluronan synthase 2 activity
With whatNot stated in the record
HowUse controlled enhancement of the naked mole-rat enzyme in aged tissue, maintaining long hyaluronan chains between injuries
Possible result
Possible suppression of pathological cell fusion through sustained availability of long hyaluronan chains
From the recordПредлагаемый способ воспроизведения: управляемое усиление гиалуронансинтазы 2 голого землекопа в старой ткани с сохранением длинных цепей между повреждениями.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
An intervention intended to extend life might also protect abnormal cells already present in old tissue. The unexpected move is to propose that those cells can remain without causing as much harm if they are prevented from merging with immune cells. This is a hypothesis generated by the pipeline, not a measured explanation of longer survival.
- Increasing naked mole-rat hyaluronan synthase 2, an enzyme that makes hyaluronan, is proposed to maintain long chains around cells in old tissue between injuries.
- Those chains would occupy CD44 and prevent abnormal epithelial cells and macrophages from starting the process of merging.
- Existing mutant cells, cells with genetic changes, could persist while producing fewer hybrids with macrophages.
- Fewer hybrids would reduce the population able to invade surrounding tissue and escape immune attack.
- Because hybrids are proposed to cause most late cancer-related harm in this setting, preventing their formation would remove the main source of that harm.
- Reduced cancer-related harm would preserve a survival advantage even when the intervention begins in old age.
Two workshops remain separate instead of combining their equipment into one workshop with a broader set of capabilities. The proposal puts the benefit in preventing that combination, even while the original workshops remain.
Where the picture breaks: Merged cells do not necessarily retain or use every capability of their parents, and merging does not necessarily make them more dangerous. The picture also cannot explain how hyaluronan binding would prevent fusion.
- Master questionstep 01 of 04
Useful natural processes might be reproduced through substances, combinations or other interventions to extend life.
Rests on: The stated goal is to generate new hypotheses about interventions that reproduce beneficial natural processes.
Stated in the chain - Goal pillarstep 02 of 04
A life-extending intervention should retain a dependable margin before its benefits turn into harm.
Rests on: The goal seeks beneficial effects that could extend life; this stage adds the requirement that those benefits withstand conditions that could reverse them.
AssumptionA dependable margin against reversal is taken as a criterion for a useful intervention. The master question does not explicitly specify that criterion.
- Gap questionstep 03 of 04
Reproducing a matrix, the material surrounding cells, rich in long hyaluronan chains might preserve a survival advantage when treatment begins in old age, or instead protect existing abnormal cell families and worsen harm after repeated injury.S5
Rests on: The preceding stage supplies the concern about benefit turning into harm. S5, published in Nature in 2023, reports longer life and improved health in mice producing long-chain hyaluronan through a naked mole-rat gene, attributing the benefit to reduced age-related inflammation, the body's injury and immune response. It does not establish benefits from starting in old age or the consequences of protecting existing abnormal cells after repeated injury.
Supported by literature - Hypothesisstep 04 of 04
Long hyaluronan chains are proposed to prevent cell fusion, the merging of cells, between abnormal epithelial cells, which form tissue linings, and macrophages, immune cells that engulf cells and debris. The proposed route runs through CD44, a cell-surface receptor that binds hyaluronan: occupying it would prevent the fusion process from starting. Fewer hybrid cells, cells formed from both parent cell types, would then mean less invasion into surrounding tissue and less escape from immune attack. The central claim is that preventing these hybrids accounts for most of the late cancer-related benefit.S6S2
Rests on: The preceding question supplies old tissue, existing abnormal cells and repeated injury. S6, published in Nature Communications in 2020, supports a role for hyaluronan–CD44 signaling in protecting cells, but does not establish suppression of fusion. S2, published in Journal of Hematology & Oncology in 2023, reports that hybrid tumor cells promoted cancer growth, spread and suppression of local immune activity in a mouse model of prostate cancer spreading to bone; it does not establish that hybrids dominate late-life cancer harm or that hyaluronan prevents their formation.
Supported by literature
What is carried, and what is not. Screened sources touch four of the six mechanism links: hyaluronan production, receptor signaling, harmful properties of some hybrids and survival benefit. S7 in Nature in 2013 supports production in a human laboratory cell line, not persistence in injured old tissue; S6 supports receptor-mediated cell protection, not fusion prevention; S2 supports harmful hybrids in a specific mouse cancer model, not their dominance in late-life harm; and S5 supports mouse lifespan extension attributed to reduced inflammation, not the proposed fusion route. No supplied source establishes the sequence end to end, and S1 in Cells in 2018 reports that the studied fusion-derived cells spread without forming overt cancerous lesions at distant sites or primary tumors at transplantation sites, limiting any general claim that hybrids necessarily cause aggressive cancer.S7S6S2S5S1
Where the reasoning is carried by something unstated · 1
- Goal pillar. A dependable margin against reversal is taken as a criterion for a useful intervention. The master question does not explicitly specify that criterion.
How a result here could mislead · 3
- A cell displaying both parental fluorescent labels, light-emitting markers used to track cells, could be counted as a hybrid even if a macrophage merely swallowed labeled debris. What closes it: The proposed test requires direct observation of merging and checking genetic markers in individual nuclei, the cell compartments holding genetic material. Fluorescence alone cannot establish fusion.
- Loss of an additional hyaluronan benefit after independently suppressing fusion could be credited to a shared mechanism even if the suppression also altered immune killing or the engulfment of cells and debris. What closes it: The independent intervention must demonstrably reduce fusion while preserving those two immune functions, as the proposal requires. Actual fusion reduction, starting mutant-cell abundance and the remaining cancer burden must be measured; the supplied design does not identify an intervention already shown to meet these requirements.
- Continued protection after introducing preformed hybrids could appear to refute the mechanism even if the introduced cells failed to survive or reach the relevant tissue. Conversely, loss of protection would not by itself show that naturally formed hybrids account for most late harm rather than another route involving the surrounding material, immune behavior or injury-released cell contents. What closes it: The introduced hybrids must be genetically verified and shown to persist in the relevant tissue at comparable abundance. Interpretation must combine this bypass test with the independent fusion-suppression test and measurements that distinguish the supplied rival routes: how the surrounding material yields under sustained cell pulling, changes in macrophage behavior and the amount of unbound injury-released cell contents.
What would make this wrong. Preservation of the full protective effect after genetically confirmed preformed hybrids have been introduced and shown to persist in the relevant tissue would contradict the claim that preventing their formation is the leading protective mechanism. Likewise, an undiminished additional hyaluronan benefit after verified independent suppression of fusion, with immune engulfment and killing preserved, would undermine the claim that fusion prevention accounts for most of the benefit.
What it would change. If the mechanism held, reproducing the separation of cell types during repair would become a candidate route to life extension: the useful effect could come from preventing dangerous combinations of cells while leaving existing mutant cells in place. Work on such interventions would need to track cell fusion and the behavior of its products alongside survival and the abundance of abnormal cells. A successful first test in cells grown together would still leave old-animal survival unestablished, and even a successful old-mouse test would not establish a benefit in humans or other tissues.
Sources read · 9
The Fate of Fusions. · Cells · 2018
“Thus, although they clearly disseminated, MTFs did not form overtly cancerous metastatic lesions in the traditional sense, and no primary tumors developed at the transplantation sites.”
Does not settle: Открытыми остаются влияние высокомолекулярного гиалуронана, блокирование CD44, усиление гиалуронансинтазы 2 голого землекопа, позднее начало вмешательства, выживаемость старых организмов и вклад клеточных гибридов в общий поздний опухолевый вред.
Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis. · Journal of hematology & oncology · 2023
“The in vivo animal experiments show that these myeloid-like hybrid tumor cells have higher tumorigenic and metastatic potential, can induce a more immunosuppressive microenvironment, and cause drug resistance.”
Does not settle: Источник не устанавливает влияние гиалуронана, CD44, гиалуронансинтазы 2 голого землекопа или поздно начатого вмешательства на продолжительность жизни. Он также не показывает, что гибриды определяют основную часть позднего опухолевого вреда, и рассматривает модель костных метастазов рака предстательной железы у мышей.
Tetraspanins and intercellular interactions. · Microcirculation (New York, N.Y. : 1994) · 2001
“Intercellularly located tetraspanins regulate the juxtacrine activity of growth factors, cell fusion, and myelin formation.”
Does not settle: The source does not establish any role for hyaluronan, CD44, hyaluronan synthase 2, epithelial cell-macrophage fusion, tumor hybrids, late-life treatment, or survival extension. It also does not test whether hybrid formation accounts for late tumor harm.
Is cancer progression caused by gradual or simultaneous acquisitions of new chromosomes? · Molecular cytogenetics · 2018
“In sum, we conclude that the seven hybridomas have descriptively and functionally distinct clonal phenotypes.”
Does not settle: Источник не устанавливает влияние гиалуронана, CD44 или гиалуронансинтазы 2 на слияние клеток. Он также не исследует гибриды патологических эпителиальных клеток и макрофагов, инвазию, уклонение от иммунитета, опухолевый вред или продолжительность жизни при позднем вмешательстве.
Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice. · Nature · 2023
“Our results demonstrate that HMM-HA produced by the nmrHas2 gene extends the lifespan and improves the healthspan of mice by ameliorating age-related inflammation.”
Does not settle: The source does not establish benefits from late-life initiation, CD44 occupancy, suppression of epithelial cell–macrophage fusion, reduced formation of invasive or immune-evasive hybrids, or hybrid formation as the main cause of late tumour-related harm.
Naked mole-rat very-high-molecular-mass hyaluronan exhibits superior cytoprotective properties. · Nature communications · 2020
“These results indicate that HA-CD44 signaling is responsible for the cytoprotection by NSF-HA.”
Does not settle: The source does not establish late-life survival extension, HAS2 induction in aged tissue, inhibition of epithelial cell–macrophage fusion, reduced hybrid formation, tumor invasion or immune evasion, or that cell hybrids account for most late tumor-related harm.
High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. · Nature · 2013
“Naked mole-rat HAS2 overexpressed in human HEK293 cells secretes HMW-HA.”
Does not settle: Источник показывает, что экспрессия гиалуронансинтазы 2 голого землекопа в клетках HEK293 приводит к выделению высокомолекулярного гиалуронана. Он не устанавливает влияние поздно начатого вмешательства на продолжительность жизни, слияние эпителиальных клеток с макрофагами, образование опухолевых гибридов, инвазию, уклонение от иммунитета или роль CD44. Также не исследованы старые ткани, повторное повреждение и сохранение длинных цепей между повреждениями.
Insights into long noncoding RNAs of naked mole rat (Heterocephalus glaber) and their potential association with cancer resistance. · Epigenetics & chromatin · 2016
“The high-molecular-mass hyaluronan (HMM-HA) was proved to play a key role in regulating the cancer resistance in NMR [ ].”
Does not settle: Источник не исследует позднее вмешательство, продолжительность жизни, связывание CD44, слияние эпителиальных клеток с макрофагами, образование опухолевых гибридов или управляемое усиление HAS2 в старой ткани.
Naked mole-rat hyaluronan. · Biochimie · 2024
“Furthermore, this adaptation indirectly confers several advantages to NMRs, such as the preservation of skin elasticity and youthful appearance, accelerated wound healing, protection against oxidative stress, and resistance to conditions such as cancer and arthritis, largely attributable to CD44 signaling and other intricate mechanisms.”
Does not settle: Открытыми остаются роль слияния эпителиальных клеток с макрофагами, влияние такого слияния на поздний опухолевый вред и продолжительность жизни, эффект позднего усиления гиалуронансинтазы 2, сохранение длинных цепей между повреждениями, а также перенос результатов на старую ткань других видов.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does starting a tissue-matrix mimic in old age extend life, or shorten it by protecting abnormal cells after repeated injuries?
Original wording · exactly as the pipeline generated it
Сохраняет ли миметик высокомолекулярного гиалуронанового матрикса преимущество продолжительности жизни при запуске в старости, или защита уже существующих патологических клонов обращает пользу во вред после повторных повреждений?
What this question is asking
The question concerns whether imitating a tissue-supporting material remains beneficial when treatment begins in old age. The proposed intervention would reproduce properties of a matrix containing long chains of hyaluronan, a substance found around cells. It asks whether treated older organisms live longer than otherwise comparable untreated organisms, including after repeated injuries and during later follow-up, or whether treatment instead protects existing groups of abnormal cells and shortens life. The question assumes an earlier lifespan benefit in genetically modified mice, but the supplied sources do not establish that result or its transfer to a mimic started in old age. No particular mimic, target species, or starting age is specified.
- Tissue matrix
- Material surrounding cells that forms part of their local environment. Here, the proposed intervention would imitate properties of a matrix containing hyaluronan.
- Mimic or mimetic
- An intervention intended to reproduce selected properties or effects of something else. No specific intervention is supplied here, so equivalence to hyaluronan treatment or genetic modification is not established.
- Hyaluronan
- A long-chain sugar molecule found in the material around cells. The supplied sources discuss both recovery after injury with long-chain hyaluronan and elevated hyaluronan or its fragments in certain cancers; those observations do not establish a single uniformly beneficial or harmful effect.
- High-molecular-weight hyaluronan
- Hyaluronan made of relatively long molecular chains. This names a size class rather than one uniquely defined molecule; the supplied material gives no numerical boundary for that class.
- Pathological clone or abnormal cell group
- A group of cells descended from a common cell and carrying a disease-related abnormality. The question concerns groups already present before treatment, but does not identify their abnormalities or establish that all such groups cause cancer.
- Pathological selection
- A process in which conditions favor the survival or expansion of disease-related cell groups over other cells. The pipeline asks whether repeated treatment and injury permit this process, but the supplied sources do not measure it.
- Transgenic mice
- Mice whose genetic material has been deliberately altered by introducing genetic material. The pipeline invokes a lifespan result in such mice without supplying the relevant study or identifying the alteration.
- Remaining lifespan
- The time lived after an intervention begins. In this question, it must include later consequences rather than only recovery immediately after injury.
- Halogens and chlorine
- Halogens are a family of chemical elements that includes chlorine. S3 and S4 concern lung or airway injury after exposure to chemicals from this family.
- Calcium ions
- Electrically charged calcium particles that can participate in signals within cells. S3 reports reversal of an increase after treatment, without establishing a connection to lifespan.
- Ras homolog family member A
- A signaling protein, conventionally abbreviated RhoA. S3 reports that treatment reversed its activation after chemical exposure; the supplied evidence does not connect that change to abnormal-cell protection.
- Airway hyperresponsiveness
- An excessive airway response to stimulation, conventionally abbreviated AHR. It is an airway-function outcome in S3, not a measurement of lifespan.
A high-molecular-weight hyaluronan matrix mimic has a lifespan advantage to preserve, based on reported lifespan extension in transgenic mice.
Hyaluronan is a material around cells, and high-molecular-weight hyaluronan consists of relatively long molecular chains. The question invokes longer life in mice whose genetic material was deliberately altered and assumes that an intervention imitating this surrounding material could reproduce that benefit. That assumption supplies the starting benefit whose persistence in old age is being questioned.
The pipeline states that genetically modified mice lived longer, but the study behind that statement is not among the supplied screened sources. S3 and S4 concern treatment with high-molecular-weight hyaluronan after chemical lung injury; neither establishes lifespan extension or equivalence between that treatment and a matrix mimic. S1 concerns hyaluronan in cancer and also does not establish the claimed lifespan benefit. This small set of background sources is insufficient to judge the premise; the missing supporting study does not make the premise false.S1S3S4
The same question asked without the part nothing read establishes:
- Does a high-molecular-weight hyaluronan matrix mimic started in old age increase or decrease remaining lifespan after repeated injuries?
- Does a high-molecular-weight hyaluronan matrix mimic protect existing abnormal cell groups after repeated injuries in old tissue?
- Remaining lifespan increases Under the proposed mechanism, tissue protection would outweigh any harmful protection of abnormal cells through repeated injuries and later follow-up. A longer remaining lifespan would establish a favorable overall outcome under those conditions, but would not by itself show that abnormal cells were unaffected.
- Remaining lifespan decreases through abnormal-cell protection Under this branch, the intervention would preserve existing abnormal cells, allowing their persistence or expansion after repeated injuries to cause enough harm to outweigh tissue protection. Improved recovery from an individual injury would then give an incomplete picture of the intervention's overall effect.
- Remaining lifespan does not change Tissue protection might fail to affect survival, or beneficial and harmful effects might balance. An unchanged lifespan alone would not distinguish those explanations or establish whether abnormal cells were protected.
The proposed benefit depends on a sequence: changing the material around cells would protect tissue, that protection would preserve function through injury, and the resulting effects would increase remaining lifespan. The proposed harm follows a different sequence: protection would also preserve abnormal cells, those cells would persist or expand through repeated injuries, and their effects would outweigh the tissue benefit. These are the question's competing possibilities, not findings established by the supplied sources. Treating recovery from an immediate injury as proof of longer life could therefore mistake a short-term benefit for a favorable lifetime outcome.
сообщает продление жизни трансгенных мышей уровня RL-2; поздний запуск при существующих патологических клонах не проверен.
Повторное действие миметика ограничивает патологический отбор и сохраняет положительный баланс оставшейся жизни, включая отсроченный период.
Требуется опровергающая проверка переноса пользы на старую клонально изменённую ткань при сохранённом воздействии на гиалуронановый матрикс.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Поздно начатый миметик высокомолекулярного гиалуронанового матрикса сохраняет преимущество продолжительности жизни преимущественно благодаря подавлению слияния патологических эпителиальных клеток с макрофагами. Длинные цепи гиалуронана занимают рецептор CD44 и препятствуют запуску программы слияния при повторном повреждении. Уже существующие мутантные клетки могут сохраняться, однако реже образуют гибриды, приобретающие дополнительные свойства инвазии и уклонения от иммунитета. Радикальное утверждение состоит в том, что именно образование гибридов определяет основную часть позднего опухолевого вреда в данном контексте. Физиологический прототип миметика представляет собой поддержание самостоятельности клеточных линий во время восстановления ткани. Предлагаемый способ воспроизведения: управляемое усиление гиалуронансинтазы 2 голого землекопа в старой ткани с сохранением длинных цепей между повреждениями.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
У старых мышей с заранее меченными патологическими клонами миметик уменьшит число клеток, содержащих подтверждённые ядерные генетические метки обеих родительских линий, и частоту инвазивных опухолей при сопоставимой численности исходных мутантных клеток. Введение заранее полученных и генетически подтверждённых гибридов обойдёт защиту миметика. Если слияние независимо подавлено при сохранённых фагоцитозе и иммунной цитотоксичности, дополнительный противоопухолевый эффект гиалуронана почти исчезнет. Сохранение полной защиты после введения гибридов опровергнет предполагаемое ведущее звено.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable reductions, conditional loss of protection, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Первую проверку можно провести в совместной культуре старого эпителия и макрофагов. Двойную флуоресценцию необходимо дополнить генотипированием отдельных ядер и наблюдением слияния, поскольку поглощение клеточных остатков тоже переносит метки. Избирательное подавление гетеротипического слияния представляет собой наиболее сложную часть причинной проверки.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
У старых мышей с заранее меченными патологическими клонами миметик уменьшит число клеток, содержащих подтверждённые ядерные генетические метки обеих родительских линий, и частоту инвазивных опухолей при сопоставимой численности исходных мутантных клеток. Введение заранее полученных и генетически подтверждённых гибридов обойдёт защиту миметика. Если слияние независимо подавлено при сохранённых фагоцитозе и иммунной цитотоксичности, дополнительный противоопухолевый эффект гиалуронана почти исчезнет. Сохранение полной защиты после введения гибридов опровергнет предполагаемое ведущее звено.
- What would separate them
Rapid relaxation of a hyaluronan matrix may promote invasion by pathological clones predicts: При одинаковых концентрации и распределении длины гиалуронана, начальной жёсткости и доступности рецепторных участков быстро релаксирующий матрикс позволит клонам распространяться дальше, чем матрикс с устойчивой упругой составляющей. Различие сохранится в культуре эпителия с фибробластами при исключённых слиянии с макрофагами и внеклеточных гистонах. Переход от коротких к длительным эпизодам клеточной тяги усилит различие в соответствии с измеренным временем релаксации. Отсутствие зависимости инвазии от релаксационного спектра при подтверждённом изменении механики опровергнет эту гипотезу.
- Rival 02 of 03What would separate them
Protein attachment to hyaluronan may shield abnormal cells by altering macrophage activity predicts: При одинаковых длине цепей и измеренной механике матрикса клоны будут сохраняться лучше в присутствии гиалуронана с ковалентно присоединёнными тяжёлыми цепями. Избирательное подавление трансферазной функции TSG-6 восстановит удаление патологических клеток, а добавление заранее сформированного комплекса вернёт их защиту. Эффект должен сопровождаться изменением активности макрофагов при сопоставимых числе контактов с мишенями и частоте клеточного слияния. Если различие исчезает после выравнивания механики, преимущество получает гипотеза диссипации.
- What would separate them
Hyaluronan may preserve late-life benefit by binding extracellular histones predicts: Избирательная нейтрализация внеклеточных гистонов воспроизведёт защиту нормальных соседей и существенно уменьшит дополнительный эффект гиалуронана. Защита сохранится в культуре с исключённым слиянием клеток и подавленным переносом тяжёлых цепей. При одинаковой механике матрикса выраженность эффекта будет следовать за снижением свободной цитотоксичной фракции гистонов. Если гиалуронан по-прежнему ограничивает клональный рост после практически полного устранения этой фракции, гипотеза теряет статус основного объяснения.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
Гиалуронан и другие лиганды CD44 подавляли образование многоядерных макрофагов. Отдельно показано образование опухолево-макрофагальных гибридов с усиленными свойствами прогрессии. Эти наблюдения поддерживают два звена предполагаемой цепи, но их соединение в механизм долголетия пока отсутствует. Источники: [CD44 Occupancy Prevents Macrophage Multinucleation](https://pmc.ncbi.nlm.nih.gov/articles/PMC2148144/); [Cell fusion potentiates tumor heterogeneity](https://pmc.ncbi.nlm.nih.gov/articles/PMC6135550/).
Биология противоопухолевого действия гиалуронановых миметиков. Пересмотра потребует учебная глава «Внеклеточный матрикс, контактное торможение и опухолевая прогрессия»: основным посредником поздней защиты окажется предотвращение объединения геномов клеточных линий.
Миметик продлит оставшуюся жизнь при практически неизменном размере исходных мутантных клонов, а небольшая добавка заранее сформированных гибридов устранит этот выигрыш при сохранённых свойствах матрикса.
Слияние опухолевых клеток с макрофагами уже обсуждается в литературе и само по себе радикальной новизной не обладает. В проведённом поиске не найден обзор, утверждающий, что подавление такого слияния объясняет основную часть продления жизни гиалуронановым миметиком при позднем начале. Полное отсутствие подобных публикаций этим поиском не доказано; соответствие строгому критерию новизны остаётся предварительным.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.